From: Clinical significance of erythropoietin receptor expression in oral squamous cell carcinoma
Variables | Number of patients | 5-Year disease-specific survival rate (%) | p-Value |
---|---|---|---|
Gender | |||
Male | 239 | 64.8 | 0.174 |
Female | 17 | 81.9 | Â |
EPOR | |||
Low expression | 146 | 73.5 | 0.0017* |
High expression | 110 | 55.9 | Â |
Age, years | |||
<60 | 202 | 67.9 | 0.142 |
≥60 | 54 | 58.6 |  |
T classification | |||
T1, T2 | 94 | 81.9 | <0.001* |
T3, T4 | 162 | 56.6 | Â |
N classification | |||
Negative | 153 | 79.4 | <0.001* |
Positive | 103 | 45.8 | Â |
TNM stage | |||
I, II | 66 | 90.9 | <0.001* |
III, IV | 190 | 57.2 | Â |